PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.53%
Revenue growth at 75-90% of MTDR's 7.77%. Bill Ackman would push for innovation or market expansion to catch up.
-16.61%
Negative gross profit growth while MTDR is at 4.90%. Joel Greenblatt would examine cost competitiveness or demand decline.
80.51%
EBIT growth above 1.5x MTDR's 6.39%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
80.51%
Operating income growth above 1.5x MTDR's 6.39%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
110.84%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
112.16%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
111.56%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.51%
Share reduction while MTDR is at 0.04%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.33%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-4.56%
Dividend reduction while MTDR stands at 33.30%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
44.87%
OCF growth 1.25-1.5x MTDR's 34.14%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
852.90%
FCF growth above 1.5x MTDR's 231.98%. David Dodd would verify if the firm’s strategic investments yield superior returns.
7.54%
10Y revenue/share CAGR under 50% of MTDR's 567.93%. Michael Burry would suspect a lasting competitive disadvantage.
-17.00%
Negative 5Y CAGR while MTDR stands at 177.78%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
75.71%
3Y revenue/share CAGR under 50% of MTDR's 261.50%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
54.05%
10Y OCF/share CAGR under 50% of MTDR's 551.82%. Michael Burry would worry about a persistent underperformance in cash creation.
64.42%
Below 50% of MTDR's 216.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
73.68%
3Y OCF/share CAGR under 50% of MTDR's 282.08%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
284.93%
Below 50% of MTDR's 812.39%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-41.80%
Negative 5Y net income/share CAGR while MTDR is 80.13%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
232.64%
3Y net income/share CAGR 50-75% of MTDR's 377.14%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
9.25%
Below 50% of MTDR's 278.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.49%
Negative 5Y equity/share growth while MTDR is at 124.03%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
157.13%
3Y equity/share CAGR at 75-90% of MTDR's 196.07%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
8.84%
Dividend/share CAGR of 8.84% while MTDR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
321.64%
Dividend/share CAGR of 321.64% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
210.30%
3Y dividend/share CAGR of 210.30% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.98%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
0.44%
Asset growth well under 50% of MTDR's 4.38%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
9.12%
1.25-1.5x MTDR's 6.47%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-5.59%
We’re deleveraging while MTDR stands at 3.06%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-80.31%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.